CYP2C9 and injury: Moreover, we found that SNPs in CYP2C8 and CYP2C9 could be a potential risk factor for both macitentan- and selexipag-induced liver injury, thus providing a possible marker for early identification of subjects with high risk of developing hepatotoxicity.